ABO blood group in primary antiphospholipid syndrome: influence in the site of thrombosis?

Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type

(2013) B. F. Sode et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Reduced prevalence of arterial thrombosis in von Willebrand disease

(2013) Y. V. Sanders et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Non-OO blood type influences the risk of recurrent venous thromboembolism

(2013) Esteban Gándara et al.   THROMBOSIS AND HAEMOSTASIS

CHANGES OF VON WILLEBRAND FACTOR DURING PREGNANCY IN WOMEN WITHOUT AND WITH VON WILLEBRAND DISEASE

(2013) Giancarlo Castaman   Mediterranean Journal of Hematology and Infectious Diseases

ABO blood group, hypercoagulability, and cardiovascular and cancer risk

(2012) Massimo Franchini et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis

(2012) Danyelle R. A. Rios et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Non-O Blood Type Is the Commonest Genetic Risk Factor for VTE: Results from a Meta-Analysis of the Literature

(2012) Francesco Dentali et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

(2011) Pier Luigi Meroni et al.   Nature Reviews Rheumatology

Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach

(2009) D.-A. Tregouet et al.   BLOOD

Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?

(2009) Yehuda Shoenfeld et al.   CURRENT OPINION IN RHEUMATOLOGY

Update of the guidelines for lupus anticoagulant detection

(2009) V. PENGO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Clinical course of high-risk patients diagnosed with antiphospholipid syndrome

(2009) V. PENGO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study

(2008) A Ruffatti et al.   ANNALS OF THE RHEUMATIC DISEASES

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor

(2008) L. Gallinaro et al.   BLOOD

Von Willebrand Factor in Cardiovascular Disease

(2008) Alexander O. Spiel et al.   CIRCULATION